ReviewCancer drug resistance (Alhambra, Calif.)2021

Targeting of PI3K/AKT signaling and DNA damage response in acute myeloid leukemia: a novel therapeutic strategy to boost chemotherapy response and overcome resistance.

Montserrat Estruch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.